空気中の病気兆候を検知するデバイス(UChicago scientists invent breakthrough device to detect airborne signs of disease)

ad

2025-05-23 シカゴ大学

シカゴ大学の研究チームは、空気中の分子を収集・検出できる小型ポータブル装置「ABLE(Airborne Biomarker Localization Engine)」を開発しました。この装置は、呼気中のグルコースや炎症マーカー、空気中の大腸菌などを検出可能で、糖尿病患者の非侵襲的な血糖モニタリングや新生児の健康管理、病院や公共空間での病原体監視など、多岐にわたる医療・公衆衛生分野への応用が期待されています。装置は約10×20cmのサイズで、空気を吸引・加湿・冷却して微粒子を液体中に凝縮し、既存の液体分析機器で検出可能な形に変換します。研究成果は2025年5月21日付で『Nature Chemical Engineering』誌に掲載されました。

<関連情報>

屋外でのポイントオブケア検出のための空中バイオマーカー定位エンジン Airborne biomarker localization engine for open-air point-of-care detection

Jingcheng Ma,Megan Laune,Pengju Li,Jing Lu,Jiping Yue,Yueyue Yu,Yamin Mansur,Amio P. D. Ritwik,Sai P. Peri,Jessica Cleary,Kaitlyn Oliphant,Zachary Kessler,Erika C. Claud &Bozhi Tian
Nature Chemical Engineering  Published:21 May 2025
DOI:https://doi.org/10.1038/s44286-025-00223-9

空気中の病気兆候を検知するデバイス(UChicago scientists invent breakthrough device to detect airborne signs of disease)

Abstract

Unlike biomarkers in biofluids, airborne biomarkers are dilute and difficult to trace. Detecting diverse airborne biomarkers with sufficient sensitivity typically relies on bulky and expensive equipment like mass spectrometers that remain inaccessible to the general population. Here we introduce airborne biomarker localization engine (ABLE), a simple, affordable and portable platform that can detect both non-volatile and volatile molecules and particulate biomarkers from open air in about 15 min. ABLE substantially improves the gas detection limits by converting dilute gases into droplets by water condensation, producing concentrated aqueous samples that can be easily tested by existing liquid-sensing platforms. Fundamental studies of multiphase condensation revealed unexpected stability in condensate-trapped biomarkers, making ABLE a reliable, accessible and high-performance system for open-air-based biosensing applications such as non-contact infant healthcare, pathogen detection in public spaces and food safety monitoring.

医療・健康
ad
ad
Follow
ad
タイトルとURLをコピーしました